PDIA3 and breast carcinoma: A previous study (Zhou et al., 2009) found that PDIA3 expression was decreased by PDIA3 siRNA in human breast cancer cells, and this inhibitory effect was abolished by a p38MAPK-specific inhibitor (SB203580), suggesting that the expression of PDIA3 requires the p38 MAPK pathway.